PYR01

• CAT Number: I041172
• CAS Number: 2560576-15-8
• Molecular Formula: C21H13F7N4O3
• Molecular Weight: 502.34
• Purity: ≥95%
• Synonyms: 5-(difluoromethyl)-3-[1-[(5-fluoro-2-oxo-1H-pyridin-3-yl)methyl]-6-oxo-4-(1,1,2,2-tetrafluoroethyl)pyrimidin-5-yl]oxy-2-methylbenzonitrile
• InChI: InChI=1S/C21H13F7N4O3/c1-9-11(5-29)2-10(17(23)24)4-14(9)35-15-16(21(27,28)20(25)26)31-8-32(19(15)34)7-12-3-13(22)6-30-18(12)33/h2-4,6,8,17,20H,7H2,1H3,(H,30,33)
• InChIKey: VZPBEVWOYXRBLB-UHFFFAOYSA-N
• SMILES: CC1=C(C=C(C=C1OC2=C(N=CN(C2=O)CC3=CC(=CNC3=O)F)C(C(F)F)(F)F)C(F)F)C#N

PYR01（Cat No.:I041172）is a novel, investigational compound being explored for its potential in treating inflammatory diseases, particularly those driven by excessive immune activation. It works by inhibiting specific pathways involved in the production of pro-inflammatory cytokines, aiming to reduce inflammation and tissue damage. PYR01 has demonstrated promising preclinical results in models of autoimmune disorders, such as rheumatoid arthritis. Researchers are currently conducting clinical trials to evaluate its safety, tolerability, and efficacy. If successful, PYR01 could provide a more targeted and effective treatment option for various inflammatory conditions.